患者エンゲージメントソリューション市場:コンポーネント別(ソフトウェア、サービス)、デリバリー別(オンプレミス、クラウド)、治療領域別(CVD、糖尿病、肥満、フィットネス)、機能別(電子処方、バーチャルケア)、エンドユーザー別(プロバイダー、支払者、患者)、地域別市場展望 2030年までの世界予測Patient Engagement Solutions Market by Component (Software, Services), Delivery (On-Premise, Cloud), Therapy Area (CVD, Diabetes, Obesity, Fitness), Functionality (E-prescribing, Virtual care), End User (Provider, Payer, Patients) & Regional Outlook Global Forecast up to 2030 この患者管理ソリューション市場の技術的、財務的、市場指向の分析のためのデータを見つけ、収集するために、この市場調査研究では、二次情報源、ディレクトリ、データベースをかなり利用しました。重要な質的・... もっと見る
サマリーこの患者管理ソリューション市場の技術的、財務的、市場指向の分析のためのデータを見つけ、収集するために、この市場調査研究では、二次情報源、ディレクトリ、データベースをかなり利用しました。重要な質的・量的データを収集・検証し、市場の将来性を評価するため、重要な業界プレーヤー、主題専門家(SME)、重要な市場プレーヤーのCレベル幹部、業界コンサルタントなどの専門家を含む、さまざまな主要回答者との詳細なインタビューを実施しました。最終的な市場規模を把握するため、様々な二次調査手法を用いて市場規模を評価し、一次調査からのインプットと三角測量した。本調査の二次情報源には、WHO、ATA、AHA、AAHMなどの政府機関の出版物が含まれる。プレスリリース、業界団体、ビジネス団体、専門家団体、ビジネス出版物や研究誌、企業や規制当局の提出書類(年次報告書、SEC提出書類、投資家向けプレゼンテーション、財務諸表など)、その他の情報源は二次情報源の一例である。世界市場の総規模は、二次データの収集と分析によって推定され、この推定値は一次調査によって確認されました。 コンポーネント別の患者管理ソリューション市場 - ハードウェア - ソフトウェア - スタンドアロンソフトウェア - 統合ソフトウェア - サービス 配信モードに基づく患者参加型ソリューション市場 - 前提モード - クラウドベース・モード 患者管理ソリューション市場:アプリケーション別 - 健康管理 - 在宅医療管理 - ソーシャル - 財務健康管理 治療分野に基づく患者エンゲージメントソリューション市場 - 慢性疾患 - 心血管疾患(CVD) - 糖尿病 - 肥満 - その他の慢性疾患 - 女性の健康 - フィットネス - その他の治療分野 機能別の患者管理ソリューション市場 - はじめに - 電子処方箋 - バーチャル診察 - 患者/顧客のスケジューリング - 文書管理 エンドユーザーに基づく患者管理ソリューション市場 - プロバイダー - 支払者 - 患者 - その他のエンドユーザー 患者管理ソリューション市場:地域別 - 北米 o 米国 カナダ - ヨーロッパ o ドイツ o イギリス o フランス o イタリア o スペイン o 残りのヨーロッパ(RoE) - アジア太平洋(APAC) o 中国 o 日本 o インド o オーストラリア o 韓国 o その他のアジア太平洋地域(RoAPAC) - ラテンアメリカ(LATAM) o ブラジル o アルゼンチン o その他の南米諸国 - 中東・アフリカ(MEA) o アラブ首長国連邦 o トルコ o サウジアラビア o 南アフリカ o その他の中東・アフリカ 2022年の市場は、ウェブとクラウドベースのセグメントが優勢であった。これらのソリューションの人気が高まっているのは、統合された機能、使いやすさ、最小限の処理コスト、データバックアップの容易さ、リアルタイムのデータ追跡へのリモートアクセスなどに起因している。上記の理由から、企業はウェブおよびクラウドベースの患者エンゲージメント・ソリューションに投資している。 例えば、マイクロソフトは2020年5月、同社初の業界特化型クラウドであるMicrosoft Cloud for Healthcareを発表した。遠隔医療やデータ分析などの機能を備えたこのプラットフォームは、医師が患者との関わりを改善し、医療チーム全体の連携を高めることを目的としている。患者データのセキュリティ、検索の利便性、アクセシビリティは、オンプレミスのサービスによって提供される。オンプレミス型サービスが好まれるのは、そのほとんどが施設内でデータにフルアクセスできるからである。 2022年に最も大きなシェアを占めたセグメントは、ソフトウェアとハードウェアであり、予測期間中の年平均成長率は約17%と最も速くなると予想される。このソリューションの主要コンポーネントは、患者エンゲージメントのためのハードウェアとソフトウェアである。ユーザーフレンドリーなインターフェースと継続的な製品アップデートにより、インストール、利用、記録の取得が容易である。オールスクリプツの人気のあるモバイルファーストのカスタマイズされた企業向け患者エンゲージメントツールは、FollowMyHealthと呼ばれている。医療提供者、病院、医療システムは、患者の幸福度を向上させ、治療の質を促進するためにこれを使用しています。 コミュニケーションはあらゆる患者エンゲージメント・ソリューションの基盤であるため、2022年の売上シェアは35.0%以上と最も高い。この大部分は、mhealth、遠隔医療、およびテキスト、ビデオ、音声を介した追加の仮想通信オプションの要件と受け入れの急増に起因する。この流行は、すでに急速に普及していた仮想通信システムの普及を加速させ、メンタルヘルス、遠隔患者モニタリング、その他多くのモダリティへの適用性を高めている。 2022年の収益シェアは40.0%を超え、慢性疾患管理が市場を牽引した。このセグメントの高いシェアは、重要な市場における高齢化、慢性疾患の頻度、COVID-19パンデミックによるデジタル技術の採用など、いくつかの要因の結果である。患者エンゲージメント・ソリューションは、病状の回避や特定を容易にし、医療提供者とともに、あるいは自分自身で管理することで、慢性疾患の管理を支援する。 2022年には、外来患者健康管理分野が市場収益の約35.0%を占め、支配的なセグメントとなった。予測期間中、その他のアプリケーション・セグメントを構成する研究開発・予防医療アプリケーション分野は、17.0%と最も速いペースで成長すると予想される。慢性疾患と診断された患者は、継続的なケアと状態の管理方法に関する教育を必要とする。医療消費者主義の高まりにより、患者はケアの計画、モニタリング、最適化に積極的に関与するようになっている。 2022年には、医療提供者の売上シェアが最も高くなり、45.0%を超えた。最も多くの患者を治療することに加え、医療提供者は、一般的な医療問題から専門的な医療問題まで、何でも相談できる第一選択者である。したがって、患者エンゲージメント・システムの最大のユーザーは、こうしたエンドユーザーである。米国のノースウェル・ヘルスは2021年12月、HIPAAのセキュリティ規制を守りつつモビリティを促進し、ポイントオブケアの医療データを交換するため、一部の臨床施設にプレイバック・ヘルスの患者エンゲージメント・プラットフォームを導入した。 患者エンゲージメント・ソリューション市場で事業を展開する主要企業には、IBM(米国)、McKesson Corporation(米国)、Allscripts(米国)、Cerner Corporation(米国)、Epic Systems Corporation(米国)、Orion Health(ニュージーランド)、GetWellNetwork(米国)、athenahealth(米国)、Oneview Healthcare(アイルランド)、MEDITECH(米国)、IQVIA(米国)などがある、Get Real Health(米国)、Cognizant(米国)、Symphony Care(米国)、Harris Healthcare(米国)、Kareo(米国)、CureMD Healthcare(米国)、eClinicalWorks(米国)、Lincor Solutions(米国)、AdvancedMD(米国)、WellStack(米国)、IQVIA(米国)、Vivify Health(米国)、Medhost(米国)、Validic(米国)MEDISYSINC(米国)、Patient point LLC(米国)。 - 本レポートは、患者管理ソリューション市場の最も重要な属性を示しており、これが市場を牽引し、機会を提供しています。 - この調査レポートは、患者管理ソリューション市場の成長を市場のいくつかのセグメントに基づいて詳細に分析します。 - 患者管理ソリューション市場の過去と現在の動向予測を提示します。 - また、患者関与ソリューション市場の主要企業の主要戦略や能力などの競争分析も提示しています。 目次Table of Contents1. Executive Summary 2. Industry Outlook 2.1. Industry Overview 2.2. Industry Trends 3. Market Snapshot 3.1. Market Definition 3.2. Market Outlook 3.2.1. Porter Five Forces 3.3. Related Markets 4. Market characteristics 4.1. Market Overview 4.2. Market Segmentation 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.4. DRO - Impact Analysis 5. Component: Market Size & Analysis 5.1. Overview 5.2. Hardware 5.3. Software 5.4. Standalone Software 5.5. Integrated Software 5.6. Services 6. Delivery mode: Market Size & Analysis 6.1. Overview 6.2. PREMISE Mode 6.3. CLOUD-BASED Mode 7. Application: Market Size & Analysis 7.1. Overview 7.2. Health management 7.3. Home health management 7.4. Social 7.5. Financial health management 8. Therapeutic Area: Market Size & Analysis 8.1. Overview 8.2. Chronic diseases 8.3. Cardiovascular diseases (CVD) 8.4. Diabetes 8.5. Obesity 8.6. Other chronic diseases 8.7. Women’s health 8.8. Fitness 8.9. Other Therapeutic Areas 9. Functionality: Market Size & Analysis 9.1. Overview 9.2. Chronic diseases 9.3. Cardiovascular diseases (CVD) 9.4. Diabetes 9.5. Obesity 9.6. Other chronic diseases 9.7. Women’s health 9.8. Fitness 9.9. Other Therapeutic Areas 10. End User: Market Size & Analysis 10.1. Overview 10.2. Chronic diseases 10.3. Cardiovascular diseases (CVD) 10.4. Diabetes 10.5. Obesity 10.6. Other chronic diseases 10.7. Women’s health 10.8. Fitness 10.9. Other Therapeutic Areas 11. Geography: Market Size & Analysis 11.1. Overview 11.2. North America (U.S., Mexico, Canada) 11.3. Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia, Rest of Europe) 11.4. Asia Pacific (Japan, China, India, Australia, South East Asia, Rest of APAC) 11.5. Latin America (Brazil, Argentina) 11.6. Middle East & Africa (Saudi Arabia, UAE, South Africa, Rest of Middle East and Africa) 12. Competitive Landscape 12.1. Competitor Comparison Analysis 12.2. Market Developments 12.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships 12.2.2. Product Launches and execution 13. Vendor Profiles 13.1. Allscripts Healthcare, LLC 13.1.1. Overview 13.1.2. Financial Overview 13.1.3. Product Offerings 13.1.4. Developments 13.1.5. Business Strategy 13.2. Orion Health 13.2.1. Overview 13.2.2. Financial Overview 13.2.3. Product Offerings 13.2.4. Developments 13.2.5. Business Strategy 13.3. Cerner Corporation 13.3.1. Overview 13.3.2. Financial Overview 13.3.3. Product Offerings 13.3.4. Developments 13.3.5. Business Strategy 13.4. Athenahealth, Inc. 13.4.1. Overview 13.4.2. Financial Overview 13.4.3. Product Offerings 13.4.4. Developments 13.4.5. Business Strategy 13.5. McKesson Corporation 13.5.1. Overview 13.5.2. Financial Overview 13.5.3. Product Offerings 13.5.4. Developments 13.5.5. Business Strategy 13.6. IBM 13.6.1. Overview 13.6.2. Financial Overview 13.6.3. Product Offerings 13.6.4. Developments 13.6.5. Business Strategy 13.7. Medecision 13.7.1. Overview 13.7.2. Financial Overview 13.7.3. Product Offerings 13.7.4. Developments 13.7.5. Business Strategy 13.8. GetWellNetwork, Inc. 13.8.1. Overview 13.8.2. Financial Overview 13.8.3. Product Offerings 13.8.4. Developments 13.8.5. Business Strategy 13.9. MEDHOST 13.9.1. Overview 13.9.2. Financial Overview 13.9.3. Product Offerings 13.9.4. Developments 13.9.5. Business Strategy 13.10. Lincor 13.10.1. Overview 13.10.2. Financial Overview 13.10.3. Product Offerings 13.10.4. Developments 13.10.5. Business Strategy 14. Analyst Opinion 15. Annexure 15.1. Report Scope 15.2. Market Definitions 15.3. Research Methodology 15.3.1. Data Collation and In-house Estimation 15.3.2. Market Triangulation 15.3.3. Forecasting 15.4. Report Assumptions 15.5. Declarations 15.6. Stakeholders 15.7. Abbreviations 図表リストTablesTABLE 1. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 2. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR HARDWARE, BY GEOGRAPHY , 2021-2030 (USD BILLION) TABLE 3. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR SOFTWARE, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 4. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR STANDALONE SOFTWARE, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 5. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR INTEGRATED SOFTWARE, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 6. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR SERVICES, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 7. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 8. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR PREMISE MODE, 2021-2030 (USD BILLION) TABLE 9. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR CLOUD-BASED MODE, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 10. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 11. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR HEALTH MANAGEMENT, 2021-2030 (USD BILLION) TABLE 12. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR HOME HEALTH MANAGEMENT, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 13. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR SOCIAL, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 14. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR FINANCIAL HEALTH MANAGEMENT, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 15. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY THERAPEUTIC AREA, 2021-2030 (USD BILLION) TABLE 16. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR CHRONIC DISEASES, 2021-2030 (USD BILLION) TABLE 17. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR CARDIOVASCULAR DISEASES (CVD), BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 18. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR DIABETES, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 19. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR OBESITY, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 20. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR CHRONIC DISEASES, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 21. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR WOMEN’S HEALTH, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 22. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR FITNESS, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 23. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY FUNCTIONALITY, 2021-2030 (USD BILLION) TABLE 24. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR INTRODUCTION, 2021-2030 (USD BILLION) TABLE 25. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR E-PRESCRIBING, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 26. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR VIRTUAL CONSULTATION, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 27. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR PATIENT/CLIENT SCHEDULING, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 28. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR DOCUMENT MANAGEMENT, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 29. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 30. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR PROVIDERS, 2021-2030 (USD BILLION) TABLE 31. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR PAYERS, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 32. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR PATIENTS, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 33. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR OTHER END USERS, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 34. NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION) TABLE 35. NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 36. NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 37. NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 38. U.S PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 39. U.S PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 40. U.S PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 41. U.S PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 42. CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 43. CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 44. CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 45. CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 46. MEXICO PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 47. MEXICO PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 48. MEXICO PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 49. MEXICO PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 50. EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION) TABLE 51. EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 52. EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 53. EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, END USE INDUSTRIES, 2021-2030 (USD BILLION) TABLE 54. EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 55. GERMANY PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 56. GERMANY PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 57. GERMANY PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 58. GERMANY PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 59. U.K PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 60. U.K PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 61. U.K PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 62. U.K PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 63. FRANCE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 64. FRANCE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 65. FRANCE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 66. FRANCE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 67. ITALY PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 68. ITALY PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 69. ITALY PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 70. ITALY PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 71. SPAIN PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 72. SPAIN PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 73. SPAIN PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 74. SPAIN PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 75. ROE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 76. ROE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 77. ROE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 78. ROE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 79. ASIA PACIFIC PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION) TABLE 80. ASIA PACIFIC PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 81. ASIA PACIFIC PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 82. ASIA PACIFIC PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 83. ASIA PACIFIC PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 84. CHINA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 85. CHINA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 86. CHINA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 87. CHINA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 88. INDIA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 89. INDIA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 90. INDIA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 91. INDIA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 92. JAPAN PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 93. JAPAN PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 94. JAPAN PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 95. JAPAN PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 96. REST OF APAC PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 97. REST OF APAC PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 98. REST OF APAC PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 99. REST OF APAC PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 100. LATIN AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 101. LATIN AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 102. LATIN AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 103. LATIN AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 104. BRAZIL PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 105. BRAZIL PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 106. BRAZIL PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 107. BRAZIL PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 108. ARGENTINA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 109. ARGENTINA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 110. ARGENTINA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 111. ARGENTINA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 112. MIDDLE EAST AND AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 113. MIDDLE EAST AND AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 114. MIDDLE EAST AND AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 115. MIDDLE EAST AND AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 116. SAUDI ARABIA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 117. SAUDI ARABIA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 118. SAUDI ARABIA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 119. SAUDI ARABIA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 120. UAE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 121. UAE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 122. UAE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 123. UAE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 124. REST OF MIDDLE EAST AND AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 125. REST OF MIDDLE EAST AND AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 126. REST OF MIDDLE EAST AND AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 127. REST OF MIDDLE EAST AND AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 128. ALLSCRIPTS HEALTHCARE, LLC: FINANCIALS TABLE 129. ALLSCRIPTS HEALTHCARE, LLC: PRODUCTS & SERVICES TABLE 130. ALLSCRIPTS HEALTHCARE, LLC: RECENT DEVELOPMENTS TABLE 131. ORION HEALTH: FINANCIALS TABLE 132. ORION HEALTH: PRODUCTS & SERVICES TABLE 133. ORION HEALTH: RECENT DEVELOPMENTS TABLE 134. CERNER CORPORATION: FINANCIALS TABLE 135. CERNER CORPORATION : PRODUCTS & SERVICES TABLE 136. CERNER CORPORATION: RECENT DEVELOPMENTS TABLE 137. MCKESSON CORPORATION: FINANCIALS TABLE 138. MCKESSON CORPORATION: PRODUCTS & SERVICES TABLE 139. MCKESSON CORPORATION: RECENT DEVELOPMENTS TABLE 140. ATHENAHEALTH, INC.: FINANCIALS TABLE 141. ATHENAHEALTH, INC.: PRODUCTS & SERVICES TABLE 142. ATHENAHEALTH, INC.: RECENT DEVELOPMENTS TABLE 143. IBM: FINANCIALS TABLE 144. IBM: PRODUCTS & SERVICES TABLE 145. IBM: RECENT DEVELOPMENTS TABLE 146. MEDECISION: FINANCIALS TABLE 147. MEDECISION: PRODUCTS & SERVICES TABLE 148. MEDECISION: DEVELOPMENTS TABLE 149. GETWELLNETWORK, INC.: FINANCIALS TABLE 150. GETWELLNETWORK, INC.: PRODUCTS & SERVICES TABLE 151. GETWELLNETWORK, INC.: RECENT DEVELOPMENTS TABLE 152. MEDHOST: FINANCIALS TABLE 153. MEDHOST: RODUCTS & SERVICES TABLE 154. MEDHOST: RECENT DEVELOPMENTS TABLE 155. LINCOR: FINANCIALS TABLE 156. LINCOR: PRODUCTS & SERVICES TABLE 157. LINCOR: RECENT DEVELOPMENTS
SummaryIn order to find and gather data for this technical, financial, and market-oriented analysis of the Patient Engagement Solutions market, this market research study made considerable use of secondary sources, directories, and databases. To gather and validate crucial qualitative and quantitative data and evaluate market prospects, in-depth interviews were performed with a range of primary respondents, including important industry players, subject-matter experts (SMEs), C-level executives of significant market players, and industry consultants, among other experts. To get the final market size, the size of the market was evaluated using a variety of secondary research techniques and triangulated with inputs from primary research. Table of ContentsTable of Contents1. Executive Summary 2. Industry Outlook 2.1. Industry Overview 2.2. Industry Trends 3. Market Snapshot 3.1. Market Definition 3.2. Market Outlook 3.2.1. Porter Five Forces 3.3. Related Markets 4. Market characteristics 4.1. Market Overview 4.2. Market Segmentation 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.4. DRO - Impact Analysis 5. Component: Market Size & Analysis 5.1. Overview 5.2. Hardware 5.3. Software 5.4. Standalone Software 5.5. Integrated Software 5.6. Services 6. Delivery mode: Market Size & Analysis 6.1. Overview 6.2. PREMISE Mode 6.3. CLOUD-BASED Mode 7. Application: Market Size & Analysis 7.1. Overview 7.2. Health management 7.3. Home health management 7.4. Social 7.5. Financial health management 8. Therapeutic Area: Market Size & Analysis 8.1. Overview 8.2. Chronic diseases 8.3. Cardiovascular diseases (CVD) 8.4. Diabetes 8.5. Obesity 8.6. Other chronic diseases 8.7. Women’s health 8.8. Fitness 8.9. Other Therapeutic Areas 9. Functionality: Market Size & Analysis 9.1. Overview 9.2. Chronic diseases 9.3. Cardiovascular diseases (CVD) 9.4. Diabetes 9.5. Obesity 9.6. Other chronic diseases 9.7. Women’s health 9.8. Fitness 9.9. Other Therapeutic Areas 10. End User: Market Size & Analysis 10.1. Overview 10.2. Chronic diseases 10.3. Cardiovascular diseases (CVD) 10.4. Diabetes 10.5. Obesity 10.6. Other chronic diseases 10.7. Women’s health 10.8. Fitness 10.9. Other Therapeutic Areas 11. Geography: Market Size & Analysis 11.1. Overview 11.2. North America (U.S., Mexico, Canada) 11.3. Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia, Rest of Europe) 11.4. Asia Pacific (Japan, China, India, Australia, South East Asia, Rest of APAC) 11.5. Latin America (Brazil, Argentina) 11.6. Middle East & Africa (Saudi Arabia, UAE, South Africa, Rest of Middle East and Africa) 12. Competitive Landscape 12.1. Competitor Comparison Analysis 12.2. Market Developments 12.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships 12.2.2. Product Launches and execution 13. Vendor Profiles 13.1. Allscripts Healthcare, LLC 13.1.1. Overview 13.1.2. Financial Overview 13.1.3. Product Offerings 13.1.4. Developments 13.1.5. Business Strategy 13.2. Orion Health 13.2.1. Overview 13.2.2. Financial Overview 13.2.3. Product Offerings 13.2.4. Developments 13.2.5. Business Strategy 13.3. Cerner Corporation 13.3.1. Overview 13.3.2. Financial Overview 13.3.3. Product Offerings 13.3.4. Developments 13.3.5. Business Strategy 13.4. Athenahealth, Inc. 13.4.1. Overview 13.4.2. Financial Overview 13.4.3. Product Offerings 13.4.4. Developments 13.4.5. Business Strategy 13.5. McKesson Corporation 13.5.1. Overview 13.5.2. Financial Overview 13.5.3. Product Offerings 13.5.4. Developments 13.5.5. Business Strategy 13.6. IBM 13.6.1. Overview 13.6.2. Financial Overview 13.6.3. Product Offerings 13.6.4. Developments 13.6.5. Business Strategy 13.7. Medecision 13.7.1. Overview 13.7.2. Financial Overview 13.7.3. Product Offerings 13.7.4. Developments 13.7.5. Business Strategy 13.8. GetWellNetwork, Inc. 13.8.1. Overview 13.8.2. Financial Overview 13.8.3. Product Offerings 13.8.4. Developments 13.8.5. Business Strategy 13.9. MEDHOST 13.9.1. Overview 13.9.2. Financial Overview 13.9.3. Product Offerings 13.9.4. Developments 13.9.5. Business Strategy 13.10. Lincor 13.10.1. Overview 13.10.2. Financial Overview 13.10.3. Product Offerings 13.10.4. Developments 13.10.5. Business Strategy 14. Analyst Opinion 15. Annexure 15.1. Report Scope 15.2. Market Definitions 15.3. Research Methodology 15.3.1. Data Collation and In-house Estimation 15.3.2. Market Triangulation 15.3.3. Forecasting 15.4. Report Assumptions 15.5. Declarations 15.6. Stakeholders 15.7. Abbreviations List of Tables/GraphsTablesTABLE 1. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 2. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR HARDWARE, BY GEOGRAPHY , 2021-2030 (USD BILLION) TABLE 3. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR SOFTWARE, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 4. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR STANDALONE SOFTWARE, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 5. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR INTEGRATED SOFTWARE, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 6. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR SERVICES, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 7. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 8. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR PREMISE MODE, 2021-2030 (USD BILLION) TABLE 9. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR CLOUD-BASED MODE, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 10. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 11. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR HEALTH MANAGEMENT, 2021-2030 (USD BILLION) TABLE 12. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR HOME HEALTH MANAGEMENT, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 13. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR SOCIAL, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 14. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR FINANCIAL HEALTH MANAGEMENT, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 15. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY THERAPEUTIC AREA, 2021-2030 (USD BILLION) TABLE 16. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR CHRONIC DISEASES, 2021-2030 (USD BILLION) TABLE 17. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR CARDIOVASCULAR DISEASES (CVD), BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 18. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR DIABETES, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 19. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR OBESITY, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 20. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR CHRONIC DISEASES, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 21. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR WOMEN’S HEALTH, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 22. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR FITNESS, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 23. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY FUNCTIONALITY, 2021-2030 (USD BILLION) TABLE 24. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR INTRODUCTION, 2021-2030 (USD BILLION) TABLE 25. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR E-PRESCRIBING, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 26. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR VIRTUAL CONSULTATION, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 27. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR PATIENT/CLIENT SCHEDULING, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 28. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR DOCUMENT MANAGEMENT, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 29. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 30. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR PROVIDERS, 2021-2030 (USD BILLION) TABLE 31. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR PAYERS, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 32. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR PATIENTS, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 33. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR OTHER END USERS, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 34. NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION) TABLE 35. NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 36. NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 37. NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 38. U.S PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 39. U.S PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 40. U.S PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 41. U.S PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 42. CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 43. CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 44. CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 45. CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 46. MEXICO PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 47. MEXICO PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 48. MEXICO PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 49. MEXICO PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 50. EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION) TABLE 51. EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 52. EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 53. EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, END USE INDUSTRIES, 2021-2030 (USD BILLION) TABLE 54. EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 55. GERMANY PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 56. GERMANY PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 57. GERMANY PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 58. GERMANY PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 59. U.K PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 60. U.K PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 61. U.K PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 62. U.K PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 63. FRANCE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 64. FRANCE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 65. FRANCE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 66. FRANCE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 67. ITALY PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 68. ITALY PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 69. ITALY PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 70. ITALY PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 71. SPAIN PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 72. SPAIN PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 73. SPAIN PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 74. SPAIN PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 75. ROE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 76. ROE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 77. ROE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 78. ROE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 79. ASIA PACIFIC PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION) TABLE 80. ASIA PACIFIC PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 81. ASIA PACIFIC PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 82. ASIA PACIFIC PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 83. ASIA PACIFIC PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 84. CHINA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 85. CHINA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 86. CHINA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 87. CHINA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 88. INDIA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 89. INDIA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 90. INDIA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 91. INDIA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 92. JAPAN PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 93. JAPAN PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 94. JAPAN PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 95. JAPAN PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 96. REST OF APAC PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 97. REST OF APAC PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 98. REST OF APAC PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 99. REST OF APAC PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 100. LATIN AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 101. LATIN AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 102. LATIN AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 103. LATIN AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 104. BRAZIL PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 105. BRAZIL PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 106. BRAZIL PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 107. BRAZIL PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 108. ARGENTINA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 109. ARGENTINA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 110. ARGENTINA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 111. ARGENTINA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 112. MIDDLE EAST AND AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 113. MIDDLE EAST AND AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 114. MIDDLE EAST AND AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 115. MIDDLE EAST AND AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 116. SAUDI ARABIA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 117. SAUDI ARABIA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 118. SAUDI ARABIA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 119. SAUDI ARABIA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 120. UAE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 121. UAE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 122. UAE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 123. UAE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 124. REST OF MIDDLE EAST AND AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 125. REST OF MIDDLE EAST AND AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 126. REST OF MIDDLE EAST AND AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 127. REST OF MIDDLE EAST AND AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 128. ALLSCRIPTS HEALTHCARE, LLC: FINANCIALS TABLE 129. ALLSCRIPTS HEALTHCARE, LLC: PRODUCTS & SERVICES TABLE 130. ALLSCRIPTS HEALTHCARE, LLC: RECENT DEVELOPMENTS TABLE 131. ORION HEALTH: FINANCIALS TABLE 132. ORION HEALTH: PRODUCTS & SERVICES TABLE 133. ORION HEALTH: RECENT DEVELOPMENTS TABLE 134. CERNER CORPORATION: FINANCIALS TABLE 135. CERNER CORPORATION : PRODUCTS & SERVICES TABLE 136. CERNER CORPORATION: RECENT DEVELOPMENTS TABLE 137. MCKESSON CORPORATION: FINANCIALS TABLE 138. MCKESSON CORPORATION: PRODUCTS & SERVICES TABLE 139. MCKESSON CORPORATION: RECENT DEVELOPMENTS TABLE 140. ATHENAHEALTH, INC.: FINANCIALS TABLE 141. ATHENAHEALTH, INC.: PRODUCTS & SERVICES TABLE 142. ATHENAHEALTH, INC.: RECENT DEVELOPMENTS TABLE 143. IBM: FINANCIALS TABLE 144. IBM: PRODUCTS & SERVICES TABLE 145. IBM: RECENT DEVELOPMENTS TABLE 146. MEDECISION: FINANCIALS TABLE 147. MEDECISION: PRODUCTS & SERVICES TABLE 148. MEDECISION: DEVELOPMENTS TABLE 149. GETWELLNETWORK, INC.: FINANCIALS TABLE 150. GETWELLNETWORK, INC.: PRODUCTS & SERVICES TABLE 151. GETWELLNETWORK, INC.: RECENT DEVELOPMENTS TABLE 152. MEDHOST: FINANCIALS TABLE 153. MEDHOST: RODUCTS & SERVICES TABLE 154. MEDHOST: RECENT DEVELOPMENTS TABLE 155. LINCOR: FINANCIALS TABLE 156. LINCOR: PRODUCTS & SERVICES TABLE 157. LINCOR: RECENT DEVELOPMENTS
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
IHR Insights社の医療分野での最新刊レポート
本レポートと同じKEY WORD(obesity)の最新刊レポート
よくあるご質問IHR Insights社はどのような調査会社ですか?IHR InsightsはICT、化学品、ヘルスケア、半導体など、世界の幅広い分野を対象に調査し、専門的な知識を基に市場調査報告書を出版しています。 主な調査分野 ◇ICT ◇化学品、材料、... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/21 10:26 156.13 円 165.08 円 200.38 円 |